He is a chemist, has several companies, and is active in the fight against global epidemics. Chemistry, business, or medicine – what interests Peter Seeberger the most? “All of it,” he says. After all, Seeberger, a professor of chemistry at Freie Universität and the head of the Biomolecular Systems department at the Max Planck Institute (MPI) of Colloids and Interfaces, combines the three fields.